McKesson Corporation (MCK)
NYSE: MCK
· Real-Time Price · USD
715.73
5.09 (0.72%)
At close: May 23, 2025, 3:59 PM
711.00
-0.66%
After-hours: May 23, 2025, 05:54 PM EDT
McKesson Revenue Breakdown
| Period Ending | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| International Segment Revenue | 14.72B | 14.13B | 20.6B | 36.34B | 35.97B | 8.3B | 7.62B | 5.91B | 5.65B | 3.61B |
| International Segment Revenue Growth | +4.18% | -31.40% | -43.33% | +1.06% | +333.05% | +9.02% | +28.97% | +4.59% | +56.41% | n/a |
| Medical-Surgical Solutions Segment Revenue | 11.39B | 11.31B | 11.11B | 11.61B | 10.1B | 183.34B | 167.76B | n/a | n/a | n/a |
| Medical-Surgical Solutions Segment Revenue Growth | +0.65% | +1.83% | -4.29% | +14.94% | -94.49% | +9.29% | n/a | n/a | n/a | n/a |
| Prescription Technology Solutions Revenue | 5.22B | 4.77B | 4.39B | 3.86B | 2.89B | n/a | n/a | n/a | n/a | n/a |
| Prescription Technology Solutions Revenue Growth | +9.37% | +8.71% | +13.54% | +33.70% | n/a | n/a | n/a | n/a | n/a | n/a |
| U.S. Pharmaceutical Segment Revenue | 327.72B | 278.74B | 240.62B | 212.15B | 189.27B | n/a | n/a | n/a | n/a | n/a |
| U.S. Pharmaceutical Segment Revenue Growth | +17.57% | +15.84% | +13.42% | +12.09% | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| International Segment Revenue | 14.72B | 14.13B | 20.6B | 36.34B | 35.97B | 38.34B | 38.02B | 38.41B | 34.1B | 32.63B |
| International Segment Revenue Growth | +4.18% | -31.40% | -43.33% | +1.06% | -6.20% | +0.84% | -1.02% | +12.63% | +4.52% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | -1.98B | 2.03B | 2.5B | 1.9B | 2.09B | 2.51B | 2.09B | 1.87B | 1.96B | 1.9B | 1.95B | 1.96B | 2.53B | 3.1B | 2.67B | 2.23B | 2.22B | 2.29B | 2.24B | 2.1B | 2.4B | 2.54B | 2.22B | 2.15B | 2.86B | 1.93B | 1.8B | 1.91B | 2.22B | 1.98B | 2.01B | 1.96B | 2.01B | 1.98B | 1.89B | 1.94B | 1.91B | 1.95B | 1.89B | 1.92B | 2.07B |
| Selling, General, and Administrative Revenue Growth | -197.39% | -18.98% | +32.08% | -9.37% | -16.56% | +19.79% | +11.87% | -4.79% | +3.21% | -2.41% | -0.46% | -22.60% | -18.49% | +16.34% | +19.58% | +0.36% | -2.92% | +2.41% | +6.32% | -12.44% | -5.21% | +14.24% | +3.35% | -24.98% | +48.14% | +7.45% | -5.77% | -13.98% | +11.79% | -1.24% | +2.29% | -2.14% | +1.31% | +5.04% | -2.53% | +1.36% | -2.20% | +3.28% | -1.41% | -7.26% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | 77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 70M | n/a | n/a | n/a | 74M | n/a | n/a | n/a | 96M | n/a | n/a | n/a | 71M | n/a | n/a | n/a | 125M | n/a | n/a | n/a | 341M | n/a | n/a | n/a | 392M | n/a | n/a | n/a | 392M |
| Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a |